Fact sheet: AXA WF Fram Health EUR

Fund information

Fund name
AXA World Funds Framlington Health F Cap USD
Fund company manager
AXA Investment Managers
Fund type
SIB
Fund manager(s)
Dani Saurymper
since 01/08/2015
Linden Thomson
since 01/08/2015
Fund objective
The Sub-Fund seeks to achieve long-term capital growth measured in USD by investing in equities and equity related instruments issued by companies engaged in healthcare and medical products and services worldwide.
Benchmark
MSCI World Healthcare
Investment style
Growth
Investment method
Shares

Performance snapshot

Sector
Fund
Sector
Fund
Sector
Fund

Quick stats

1 Year return

7.78 %

1 Year rank in sector

21/30

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 93.5 m

FE Risk score

143

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    67.09%
  • UK
    10.64%
  • Switzerland
    5.24%
  • Japan
    3.85%
  • Germany
    3.47%
  • Pharmaceuticals
    23.45%
  • Biotechnology/Medical
    16.83%
  • Healthcare & Medical Products
    14.83%
  • Health Care
    12.92%
  • Others
    7.98%
  • US Equities
    67.09%
  • UK Equities
    10.64%
  • Swiss Equities
    5.24%
  • Japanese Equities
    3.85%
  • German Equities
    3.47%

Performance vs. Sector

Sector
Fund
Sector
Fund
Sector
Fund

Cumulative performance

1m6m1y3y5y
Fund0.78 %4.87 %8.71 %14.63 %82.5 %
Sector1.39 %7.55 %14.37 %21.85 %103.82 %
Rank within sector18 / 3122 / 3121 / 3018 / 2818 / 24
Quartile th3 rd3 rd3 rd3 rd3 rd

Calendar performance

YTD-20172016201520142013
Fund13.31 %-9.99 %5.96 %21.98 %36.4 %
Sector16.98 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector20 / 3014 / 3018 / 2821 / 2514 / 24
Quartile th3 rd2 nd3 rd4 th3 rd

Risk statistics

Alpha-0.62
Beta0.8
Sharpe0.1
Volatility13.29
Tracking error6.07
Information ratio-0.3
R-Squared0.85

Price movement

52 week high243.42
52 week low201.53
Current bid price0
Current offer price0
Current mid price236.1

Holdings by region

  • 67.09% USA
  • 10.64% UK
  • 5.24% Switzerland
  • 3.85% Japan
  • 3.47% Germany
  • 2.43% Belgium
  • 2.42% France
  • 2.19% Netherlands
  • 1.84% Money Market
  • 0.83% Sweden

Holdings by sector

  • 23.45% Pharmaceuticals
  • 16.83% Biotechnology/Medical
  • 14.83% Healthcare & Medical Products
  • 12.92% Health Care
  • 7.98% Others
  • 5.9% Household Goods
  • 4.91% Health Care - Property
  • 4.67% Machinery
  • 2.48% Leisure & Hotels
  • 2.14% Leisure

Holdings by asset type

  • 67.09% US Equities
  • 10.64% UK Equities
  • 5.24% Swiss Equities
  • 3.85% Japanese Equities
  • 3.47% German Equities
  • 2.43% Belgian Equities
  • 2.42% French Equities
  • 2.19% Dutch Equities
  • 1.84% Money Market
  • 0.83% Swedish Equities

Individual holdings

  • 5.32% UNITEDHEALTH GROUP INC
  • 5.11% GLAXOSMITHKLINE PLC
  • 4.56% ALLERGAN PLC
  • 4.44% CELGENE CORP
  • 3.28% THERMO FISHER SCIENTIFIC INC
  • 2.98% LILLY (ELI) & CO
  • 2.97% ANTHEM INC
  • 2.94% VENTAS INC
  • 2.67% JULIUS BAER GRUPPE AG
  • 2.66% BIOGEN INC